Next Article in Journal
Repurposing Atovaquone as a Therapeutic against Acute Myeloid Leukemia (AML): Combination with Conventional Chemotherapy Is Feasible and Well Tolerated
Next Article in Special Issue
First- versus Third-Generation EGFR Tyrosine Kinase Inhibitors in EGFR-Mutated Non-Small Cell Lung Cancer Patients with Brain Metastases
Previous Article in Journal
Blood–Brain Barrier Disruption (BBBD)-Based Immunochemotherapy for Primary Central Nervous System Lymphoma (PCNSL), Early Results of a Phase II Study
Previous Article in Special Issue
Preclinical Models of Low-Grade Gliomas
 
 
Review

Article Versions Notes

Cancers 2023, 15(4), 1342; https://doi.org/10.3390/cancers15041342
Action Date Notes Link
article xml file uploaded 20 February 2023 12:15 CET Original file -
article xml uploaded. 20 February 2023 12:15 CET Update https://www.mdpi.com/2072-6694/15/4/1342/xml
article pdf uploaded. 20 February 2023 12:15 CET Version of Record https://www.mdpi.com/2072-6694/15/4/1342/pdf
article html file updated 20 February 2023 12:16 CET Original file -
article html file updated 9 March 2023 21:25 CET Update https://www.mdpi.com/2072-6694/15/4/1342/html
Back to TopTop